HCPLive

AUGUST 19, 2024

In this episode, hosts react to the announced CMS list prices for the first 10 drugs chosen for negotiation as part of the Inflation Reduction Act.

CMS 105

CMS Diabetes 105

CardiacWire

AUGUST 18, 2024

Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time. Between 2026 and 2029, CMS will select 60 targeted meds based on a range of factors (costs, usage, “single-source,” lack of generics, etc.)

Medicare 59

Medicare CMS Drug Costs Diabetes 59

CardiacWire

MARCH 24, 2024

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

Medicare 59

Medicare Obesity CMS Medicaid 59

Stroke Journal

JANUARY 30, 2025

We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Patients with diabetes (aOR, 95% CI: 2.99, 1.25-7.15) Model fit was assessed using the Hosmer-Lemeshow test.Results:Among 142 eligible pre-ICH statin users (median age [IQR]: 77.5 [72-86]

Medicare 40

Medicare CMS Medicaid Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In multivariate regression analysis, the factors independently associated with a greater risk of readmission within 90 days were hypercoagulation (1.359 [95%CI, 1.1274‐1.45]), opiod abuse and dependence (1.353 [95%CI, 1.238‐1.478]), chronic kidney disease (1.347 [95%CI, 1.316‐1.379]), liver disease (1.318 [95% CI, 1.26‐1.378]),

Risk Factors 40

Risk Factors Strokes Stroke Medicare 40

Cardiometabolic Health Congress

DECEMBER 9, 2024

Diabetes care, especially helping patients with type 2 diabetes, comes with a set of challenges. Let’s discuss the current challenges and actionable steps to integrate CGM and other digital tools into diabetes care. Step 1: Educating Patients on CGM Benefits A critical first step is education.

Diabetes 52

Diabetes Technology Education CMS 52